Colomb Medica

The most recent articles from: Colomb Medica December 2016

Colomb Medica · Dec 2016

Treatment of post-transplantation lymphoproliferative disorders after kidney transplant with rituximab and conversion to m-TOR inhibitor.

Post-transplantation lymphoproliferative disorders are serious complications of organ transplantation which treatment is not yet standardized. ⋯ There are no standardized treatment regimens for lymphoproliferative disorders after kidney transplantation, but these patients can be managed successfully with reduction of immunosuppression, conversion to m-TOR and rituximab-based schemes.

expand abstract… or not…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,694,794 articles already indexed!